The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Size Of The COVID-19 Saliva Screening Test Potential Market In 2026 And How Much Will It Reach By 2030?
The potential market size for covid-19 saliva screening tests has demonstrated strong growth in recent years. This market is anticipated to increase from $4.28 billion in 2025 to $4.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The historical growth of this market can be attributed to the discomfort of swab-based testing, the requirement for frequent screening, concerns related to infection control, the demand for scalable testing solutions, and the response to public health emergencies.
The covid-19 saliva screening test potential market is anticipated to experience robust growth in the coming years, projected to reach $6.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This growth during the forecast period stems from factors such as upcoming pandemic preparedness strategies, the expansion of decentralized diagnostics, increased workplace testing, demand for cost-effective mass screening, and innovations in saliva-based technologies. Significant trends for the forecast period include a move towards non-invasive testing methods, the broadening of large-scale community screening, increasing acceptance of self-collection testing, deployment in high-traffic public locations, and integration with workplace safety programs.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp
What Primary Factors Are Fueling The Expansion Of The COVID-19 Saliva Screening Test Potential Market?
Rising healthcare expenditure is projected to advance the growth of the COVID-19 saliva screening test potential market moving forward. Healthcare expenditure represents the total funds allocated to services and products related to health, encompassing prescription drugs, hospital stays, doctor visits, medical equipment, and public health campaigns. This spending is escalating due to several reasons, such as the adoption of minimally invasive surgeries, state-of-the-art diagnostic tools, an uptick in research and development for new drugs, increased utilization of healthcare services, and specialized medications. Enhanced healthcare expenditure can supply the crucial resources and backing needed to fully utilize the capabilities of COVID-19 saliva screening tests, leading to more effective pandemic management and superior public health outcomes. For example, in December 2024, the U.S. Centers for Medicare & Medicaid Services (CMS), a US-based federal health agency, reported that national health-care spending increased by 7.5%, reaching US $4.9 trillion, when compared to the preceding year. Thus, the increasing healthcare expenditure is propelling the expansion of the COVID-19 saliva screening test potential market.
Which Segment-Based Categories Are Covered In The COVID-19 Saliva Screening Test Potential Market?
The covid-19 saliva screening test potential market covered in this report is segmented –
1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing, Decentralized Testing
Subsegments:
1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports
2) By Sports Arenas: Stadiums, Arenas, Event Halls
3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs
4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks
5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas
6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites
7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers
Which Trends Are Expected To Shape The COVID-19 Saliva Screening Test Potential Market?
Major companies active in the prospective market for COVID-19 saliva screening tests are focused on creating innovative technologies, including data-sharing platforms. These platforms are designed to improve real-time communication and collaboration among healthcare providers, laboratories, and public health authorities, ultimately enhancing the efficiency and accuracy of testing, tracking, and response initiatives during the pandemic. Data-sharing platforms are digital systems that facilitate the secure exchange of data among various stakeholders, such as healthcare providers, researchers, and organizations. They promote collaboration and information access to elevate decision-making, efficiency, and results across sectors. For instance, in May 2024, the US-based healthcare network Mount Sinai Health System unveiled the Center for Healthcare Readiness. This Center is dedicated to improving strategies for public health emergency responses, ensuring that healthcare systems can competently manage extensive crises like pandemics or natural disasters. It seeks to bolster the capacity of the Mount Sinai Health System and work with local, regional, and federal partners to formulate comprehensive preparedness plans.
Who Are The Leading Firms Participating In The COVID-19 Saliva Screening Test Potential Market?
Major companies operating in the covid-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene
Access The Complete COVID-19 Saliva Screening Test Potential Market Report:
Which Region Holds The Largest Share In The COVID-19 Saliva Screening Test Potential Market?
North America was the largest region in the COVID-19 saliva screening test potential market in 2025. The regions covered in the covid-19 saliva screening test potential market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access COVID-19 Saliva Screening Test Potential Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=16026&type=smp
Browse Through More Reports Similar to the Global COVID-19 Saliva Screening Test Potential Market 2026, By The Business Research Company
Covid 19 Rapid Test Kits Market 2026
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market
Covid 19 Saliva Screening Test Potential Global Market Report 2026
Infectious Disease Diagnostics Testing Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model